Aesthetic distributor Merz Aesthetics will introduced a new cellulite treatment to the UK and Ireland in early 2017.
The Cellfina System aims to treat stubborn cellulite on the buttocks and thighs and create results that last up to two years.
The device works by releasing the fibrous septae, that cause the dimpled appearance of cellulite, through a targeted subcision approach. A vacuum assisted tissue capture platform is placed over the dimples, which provides control of the depth at 6 or 10mm and an area of release, resulting in a smoother appearance.
According to the company, the procedure does not require an operating room or general anaesthesia and takes around 45-60 minutes and involves little downtime.
In a US Food and Drug Association-cleared pivotal study, 55 patients underwent a single treatment with the Cellfina System, and results suggested that there was an improvement in the appearance of cellulite in 98% of the treatment patients at two years with a 96% patient satisfaction.
Merz Aesthetics says the device has already been a success in the US, is approved by the Food and Drug Administration and is also CE marked.
Managing director of Merz Aesthetics, Stuart Rose, said, “The European clearance of Cellfina emphasises Merz’s commitment to innovation and demonstrates our ongoing leadership in global aesthetics. With the launch into the UK and Ireland, we are able to offer our customers a proven solution to help meet the needs of women who struggle with cellulite. Both practitioners and patients can be confident that a single 45 to 60 minute treatment with Cellfina will deliver meaningful improvement in the appearance of cellulite on the buttocks and thighs and give women results that are genuine and lasting.”
Following the introduction of the Cellfina System next year, a dedicated UK website will be launched as well as clinic merchandising, and training programmes and media support.